Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

著者: J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, Claudio Cricelli, Harald Darius, Philip B. Gorelick, George Howard, Thomas A. Pearson, Peter M. Rothwell, Luís M. Ruilope, Michał Tendera, Gianni Tognoni - The Lancet 2018 被引用: 875